Luedeking-Piret Model Advances Multi-Step mAb Forecasting
In the rapidly evolving landscape of biopharmaceutical manufacturing, monoclonal antibodies (mAbs) have surged to the forefront as indispensable therapeutic agents. Their complex production processes, however,...
















